Diagnostic values of beta-2 transferrin and beta-trace protein as markers for cerebrospinal fluid fistula

Rhinology

Volumn 46, Issue 2, 2008, Pages 82-85

  Bachmann Harildstad, Gregor ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

trace protein; 2 transferrin; Cerebrospinal fluid; Complication; Fistula; Liquorrhea; Prostaglandin H2 D isomerase; Protein isoforms; Skull base; Surgery

Indexed keywords

BIOLOGICAL MARKER; ISOMERASE; LIPOCALIN; PROSTAGLANDIN R2 D ISOMERASE; PROSTAGLANDIN R2 D-ISOMERASE; TRANSFERRIN;

CEREBROSPINAL FLUID; FISTULA; HUMAN; METABOLISM; NEUROLOGIC DISEASE; PREDICTIVE VALUE; REVIEW;

BIOLOGICAL MARKERS; CEREBROSPINAL FLUID; FISTULA; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; TRANSFERRIN;

EID: 44849091533     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Durand ML, Calderwood SB, Weber DJ et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328: 21-28.
2. Eljamel MS and Foy PM. Acute traumatic CSF fistulae: the risk of intracranial infection. Br J Neurosurg 1990; 4: 381-385.
3. Bernal-Sprekelsen M, Bleda-Vazquez C, Carrau RL. Ascending meningitis secondary to traumatic cerebrospinal fluid leaks. Am J Rhinol 2000; 14: 257-259.
4. Crawford C, Kennedy N, Weir WR. Cerebrospinal fluid rhinorrhoea and Haemophilus influenzae meningitis 37 years after a head injury. J Infect 1994; 28: 93-97.
5. Salca HC and Danaila L. Onset of uncomplicated cerebrospinal fluid fistula 27 years after head injury: case report. Surg Neurol 1997; 47: 132-133.
6. Boenninghaus HG. Recurrent meningitides as sequelae of earlier skull base fractures. HNO 1968; 16: 1-6.
7. Novotny O. Recurrent meningococcic meningitis after an old temporal bone fracture. Wien Klin Wochenschr 1958; 70: 674-675.
8. Hegazy HM, Carrau RL, Snyderman CH. Transnasal endoscopic repair of cerebrospinal fluid rhinorrhea: a meta- analysis. Laryngoscope 2000; 110: 1166-1172.
9. Meurman OH, Irjala K, Suonpaa J et al. A new method for the dentification of cerebrospinal fluid leakage. Acta Otolaryngol 1979; 87: 366-369.
10. Nandapalan V, Watson ID, Swift AC. Beta-2-transferrin and cerebrospinal fluid rhinorrhoca. Clin Otolaryngol 1996; 21: 259-264.
11. Oberascher G and Arrer E. First clinical experience with beta-2 transferrin in otorrhea or rhinoliquorrhea. HNO 1986; 34: 151-155.
12. Oberascher G and Arrer E. Efficiency of various methods of identifying cerebrospinal fluid in oto- and rhinorrhea. ORL 1986; 48: 320-325.
13. Ryall RG, Peacock MK, Simpson DA. Usefulness of beta 2-transferrin assay in the detection of cerebrospinal fluid leaks following head injury. J Neurosurg 1992; 77: 737-739.
14. Skedros DG, Cass SP, Hirsch BE et al. Sources of error in use of beta-2 transferrin analysis for diagnosing perilymphatic and cerebral spinal fluid leaks. Otolaryngol Head Neck Surg 1993; 109: 861-864.
15. Skedros DG, Cass SP, Hirsch BE et al. Beta-2 transferrin assay in clinical management of cerebral spinal fluid and perilymphatic fluid leaks. J Otolaryngol 1993; 22: 341-344.
16. Solomon P, Chen J, D'Costa M et al. Extracranial drainage of cerebrospinal fluid: a study of beta- transferrins in nasal and lymphatic tissues. Laryngoscope 1999; 109: 1313-1315.
17. Toquet J, Bordure P, Herman P et al. The value of beta-2 transferrin analysis and MR cisternography for the diagnosis of cerebrospinal fluid fistulas. Ann Otolaryngol Chir Cervicofac 1998; 115: 293-298.
18. Warnecke A, Averbeck T, Wurster et al. Diagnostic relevance of beta2-transferrin for the detection of cerebrospinal fluid fistulas. Arch Otolaryngol Head Neck Surg 2004; 130: 1178-1184.
19. Papadea C and Schlosser RJ. Rapid method for beta2-transferrin in cerebrospinal fluid leakage using an automated immunofixation electrophoresis system. Clin Chem 2005; 51: 464-470.
20. Gorogh T, Rudolph P, Meyer JE et al. Separation of beta2-transferrin by denaturing gel electrophoresis to detect cerebrospinal fluid in ear and nasal fluids. Clin Chem 2005; 51: 1704-1710.
21. Zaret DL, Morrison N, Gulbranson R et al. Immunofixation to quantify beta 2-transferrin in cerebrospinal fluid to detect leakage of cerebrospinal fluid from skull injury. Clin Chem 1992; 38: 1908-1912.
22. Poupon RE, Papoz L, Sarmini H et al. A study of the microheterogeneity of transferrin in cirrhotic patients. Clin Chim Acta 1985; 151: 245-251.
23. Stibler H and Hultcrantz R. Carbohydrate-deficient transferrin in serum in patients with liver diseases. Alcohol Clin Exp Res 1987; 11: 468-473.
24. Clausen J. Proteins in normal cerebrospinal fluid not found in serum. Proc Soc Exp Biol Med 1961; 107: 170-172.
25. Petereit HF, Bachmann G, Nekic M et al. A new nephelometric assay for beta-trace protein (prostaglandin D synthase) as an indicator of liquorrhoea. J Neurol Neurosurg Psychiatry 2001; 71: 347-351.
26. Hoffmann A, Conradt HS, Gross G et al. Purification and chemical characterization of beta-trace protein from human cerebrospinal fluid: Its identification as prostaglandin D synthase. J Neurochem 1993; 61: 451-456.
27. Huber AR. Zur neuen Diagnostik von Liquorfisteln. HNO 2000; 48: 478-488.
28. Bachmann G, Djenabi U, Jungehülsing M et al. Incidence of occult cerebrospinal fluid fistula during paranasal sinus surgery. Arch Otolaryngol Head Neck Surg 2002; 128: 1299-1302.
29. Bachmann-Harildstad G. Incidence of CSF fistula after paranasal sinus surgery: the Northern Norwegian experience. Rhinology 2007; 45: 305-307.
30. Meco C, Arrer E, Oberascher G. Efficacy of cerebrospinal fluid fistula repair: sensitive quality control using the beta-trace protein test. Am J Rhinol 2007; 21: 729-736.
31. Felgenhauer K, Schädlich HJ, Nekic M. Beta-trace protein as marker for cerebrospinal fluid fistula. Klin Wochenschr 1987; 65: 764-768.
32. Melegos DN, Grass L, Pierratos A et al. Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology 1999; 53: 32-37.
33. Reiber H, Walther K, Althaus H. Beta-trace protein as sensitive marker for CSF rhinorhea and CSF otorhea. Acta Neurol Scand 2003; 108: 359-362.
34. Risch L, Lisec I, Jutzi M et al. Rapid, accurate and non-invasive detection of cerebrospinal fluid leakage using combined determination of beta-trace protein in secretion and serum. Clin Chim Acta 2005; 351: 169-176.
35. Keerl R, Weber RK, Draf W et al. Use of sodium fluorescein solution for detection of cerebrospinal fluid fistulas: an analysis of 420 administrations and reported complications in Europe and the United States. Laryngoscope 2004; 114: 266-272.
36. Meco C, Oberascher G, Arrer E et al. Beta-trace protein test: new guidelines for the reliable diagnosis of cerebrospinal fluid fistula. Otolaryngol Head Neck Surg 2003; 129: 508-517.